497 related articles for article (PubMed ID: 487808)
1. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
Newton J; Szontagh F; Lebech P; Rowe P
Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
[TBL] [Abstract][Full Text] [Related]
2. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
[TBL] [Abstract][Full Text] [Related]
3. Hormonal intrauterine devices.
Rybo G; Andersson K; Odlind V
Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
5. Five years private practice experience of nulliparous women using copper IUD's.
Smith RP; Goresky DM; Etchell DM
Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
[TBL] [Abstract][Full Text] [Related]
6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
7. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with the uterine progesterone system (Progestasert R).
Zador G; Nilsson BA; Nilsson B; Sjöberg NO; Weström L; Wiese J
Contraception; 1976 May; 13(5):559-69. PubMed ID: 1261259
[TBL] [Abstract][Full Text] [Related]
9. Clinical study of a progesterone-releasing intrauterine contraceptive device.
Brenner PF; Cooper DL; Mishell DR
Am J Obstet Gynecol; 1975 Mar; 121(5):704-6. PubMed ID: 1115173
[TBL] [Abstract][Full Text] [Related]
10. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
Lavin P; Waszak C; Bravo C
Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
[TBL] [Abstract][Full Text] [Related]
11. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Van Vliet H; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Helmerhorst F; Guillebaud J
Cochrane Database Syst Rev; 2004; 2004(3):CD001776. PubMed ID: 15266453
[TBL] [Abstract][Full Text] [Related]
12. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
13. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
Custo GM; Cosmi EV
Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
[TBL] [Abstract][Full Text] [Related]
14. Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T.
Fylling P; Fagerhol M
Fertil Steril; 1979 Feb; 31(2):138-41. PubMed ID: 761675
[TBL] [Abstract][Full Text] [Related]
15. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
17. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
18. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
[TBL] [Abstract][Full Text] [Related]
19. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
20. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
